Skip to main content

Peer Review reports

From: A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity

Original Submission
27 Jan 2014 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Author responded Author comments
Resubmission - Version 5
Submitted Manuscript version 5
Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
26 Feb 2015 Editorially accepted
25 Mar 2015 Article published 10.1186/s12885-015-1140-1

You can find further information about peer review here.

Back to article page
\